京东健康股份有限公司(股票代码:6618.HK)今日发布的2024年全年业绩公告,以总收入582亿元、Non-IFRS净利润47.9亿元的亮眼数据,再次验证其作为中国互联网医疗龙头企业的增长韧性。在医药电商增速整体放缓的背景下,京东健康通过供应链深化、服务闭环构建及AI技术规模化应用,成功开辟“严肃医疗+消费健康”双轮驱动的增长路径。本文将从财务表现、业务创新、投资逻辑及未来潜力四个维度,解码其...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.